NGL FINECHEM
Back to Income Statement
|
NGL FINECHEM Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹339 Cr | ₹278 Cr | ₹318 Cr | ₹258 Cr | ₹15,168,639 Cr |
What is the latest Revenue of NGL FINECHEM ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹339 Cr |
| Mar2024 | ₹278 Cr |
| Mar2023 | ₹318 Cr |
| Mar2022 | ₹258 Cr |
| Mar2021 | ₹15,168,639 Cr |
How is Revenue of NGL FINECHEM Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹339 Cr | 21.79 | |
| Mar2024 | ₹278 Cr | -12.42 | |
| Mar2023 | ₹318 Cr | 23.08 | |
| Mar2022 | ₹258 Cr | -100.00 | |
| Mar2021 | ₹15,168,639 Cr | - | |
Compare Revenue of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹936.2 Cr | -0.9% | 15.6% | -5.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | -0.9% |
15.6% |
-5.9% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses